Lv3
308 积分 2021-12-23 加入
Five‐Year Follow‐Up: Tandem CD19 / CD20 CAR T Therapy Enduring Impact on Refractory/Relapsed Non‐Hodgkin Lymphoma
24天前
已完结
CAR immune cells: design principles, resistance and the next generation
24天前
已完结
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
24天前
已完结
Phase 1 Study of Anito-cel, a d -Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
25天前
已完结
TIM3-targeted delivery of venetoclax overcomes drug resistance and reinvigorates NK cell activity in acute myeloid leukemia
1个月前
已完结
Discovery and design of potent cell surface display elements
1个月前
已完结
Intratumoral T cell activation kills tumors regardless of T cell specificity
1个月前
已完结
Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus
1个月前
已完结
Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy
1个月前
已完结
A guide to CAR T cell therapies: development, current status and future prospects
1个月前
已完结
皖公网安备34019202002308
